子社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 邻近社群 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] 社群统计 近3年内发表的文件:335(13.91%) 含全文笔数:2250(93.40%) 文件下载次数统计 下载大于0次:2250(100.00%) 下载大于100次:2250(100.00%) 全文下载总次数:1608490(30.01%) 最后更新时间: 2024-11-28 15:40 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目176-200 / 2409. (共97页) << < 3 4 5 6 7 8 9 10 11 12 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2023-03	ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression	Cancer Research. 2023 Mar 15;83(6):830-844.
2023-02-28	Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma	Frontiers in Oncology. 2023 Feb 28;13:Article number 1096683.
2023-02-25	Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder	World Journal of Surgical Oncology. 2023 Feb 25;21(1):Article number 62.
2023-02-24	Deciphering the functions of telomerase reverse transcriptase in head and neck cancer	Biomedicines. 2023 Feb 24;11(3):Article number 691.
2023-02-05	Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer	Cancers. 2023 Feb 5;15(4):Article number 1008.
2023-02-03	MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition	Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
2023-02-01	Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers	Cancer Letters. 2023 Feb 1;554:Article number 216008.
2023-02	A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment	Cancer Immunology Immunotherapy. 2023 Feb;72(2):351-369.
2023-02	ASO visual abstract: Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment	Annals of Surgical Oncology. 2023 Feb;30(2):1182-1183.
2023-02	Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment	Annals of Surgical Oncology. 2023 Feb;30(2):1169-1181.
2023-02	The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan	ESMO Open. 2023 Feb;8(1):Article number 100746.
2023-02	Augmenting DSM-5 diagnostic criteria with self-attention-based BiLSTM models for psychiatric diagnosis	Artificial Intelligence in Medicine. 2023 Feb;136:Article number 102488.
2023-02	Deep-learning based breast cancer detection for cross-staining histopathology images	Heliyon. 2023 Feb;9(2):Article number e13171.
2023-01-30	Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma	Cancers. 2023 Jan 30;15(3):Article number 854.
2023-01-27	The biological impacts of CEBPD on urothelial carcinoma development and progression	Frontiers in Oncology. 2023 Jan 27;13:Article number 1123776.
2023-01-21	Adjuvant therapy in biliary tract cancers: Oral fluoropyrimidine as a beginning	Lancet. 2023 Jan 21-27;401(10372):170-171.
2023-01-20	ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance	iScience. 2023 Jan 20;26(1):Article number 105881.
2023-01-19	Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma	New England Journal of Medicine. 2023 Jan 19;388(3):228-239.
2023-01-19	Actin-like protein 6A expression correlates with cancer stem cell-like features and poor prognosis in ovarian cancer	International Journal of Molecular Sciences. 2023 Jan 19;24(3):Article number 2016.
2023-01-06	Visible CCD camera-guided photoacoustic imaging system for precise navigation during functional rat brain imaging	Biosensors. 2023 Jan 6;13(1):Article number 107.
2023-01	TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIdelta/AKT pathway	Journal of Advanced Research. 2023 Jan;43:45-57.
2023-01	Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway	Cancer Medicine. 2023 Jan;12(2):1588-1601.
2023-01	A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer	Neoplasia. 2023 Jan;35:Article number 100856.
2022-12-31	Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019	Viruses. 2022 Dec 31;15(1):Article number 126.
2022-12-28	Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan	Scientific Reports. 2022 Dec 28;12:Article number 22492.

显示项目176-200 / 2409. (共97页) << < 3 4 5 6 7 8 9 10 11 12 > >> 每页显示[10|25|50]项目